Preliminary Analysis of the Proportion and Characteristics of Dual BCR B Cells in SLE Model Mice and Patients via scRNA-Seq Combined with scBCR-Seq Technology. [PDF]
Quan K +6 more
europepmc +1 more source
Objectives To evaluate the impact of the presence, extent and location of positive surgical margins (PSMs) on the risk of biochemical recurrence (BCR) and metastases in a nationwide cohort of patients who underwent radical prostatectomy (RP) and had 5 years of follow‐up.
Joost van Drumpt +10 more
wiley +1 more source
A Metabolic-Related Gene Signature for Predicting Biochemical Recurrence After Radical Prostatectomy: An Integrative Analysis and Targeted Therapeutic Validation. [PDF]
Wang W +7 more
europepmc +1 more source
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives
Riccardo Rondanin +11 more
openalex +2 more sources
BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
Michele Stanchina +5 more
openalex +1 more source
Evaluation of Heavy Metals in Soil Using Modified BCR Sequential Extraction [PDF]
Hafsat Tukur Rumah
openalex +1 more source
Guideline of guidelines: pelvic lymph node dissection at time of radical prostatectomy
Objective To provide a comprehensive review, analysis and critique of guidelines from various oncological and urological organisations regarding the use pelvic lymph node dissection (PLND) in men undergoing radical prostatectomy (RP) for primary treatment of prostate cancer (PCa).
Jonathon Carll +8 more
wiley +1 more source
The Steroidal Profile Modulates Adaptive Immune Response and Prognosis in Adrenocortical Carcinoma: Analysis of TCR and BCR Repertoires. [PDF]
de Souza Resende JS +6 more
europepmc +1 more source
Using the EPIDEM Model of Quality Improvement to Increase Value ofBCR-ABL1Tests [PDF]
Feng Yin +4 more
openalex +1 more source
Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy
Objectives To evaluate biochemical recurrence‐free survival (BRFS) and metastasis‐free survival (MFS) as potential intermediate clinical endpoints (ICEs) for overall survival (OS) in patients undergoing salvage radical prostatectomy (sRP). Patients and Methods Evaluable patients were selected from a retrospective dataset, resulting in a cohort of 879 ...
Navid Roessler +22 more
wiley +1 more source

